Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 2016;80:179–89.
Joyner KJ, Patrick CJ, Morris DH, McCarthy DM, Bartholow BD. Variants of the P3 event-related potential operate as indicators of distinct mechanisms contributing to problematic alcohol use. Neuropsychopharmacology. 2024 https://doi.org/10.1038/s41386-024-01874-7.
Bel-Bahar TS, Khan AA, Shaik RB, Parvaz MA. A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment. Front Hum Neurosci. 2022;16:995534.
Funding
EC is supported by NIH grants R21 DA057071 and P50 AA022538.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Childs, E. Reframing addiction: It’s not the destination, but the journey. Neuropsychopharmacol. 49, 1807–1808 (2024). https://doi.org/10.1038/s41386-024-01989-x
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41386-024-01989-x